Fennec Pharmaceuticals Inc.

FENC

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001211583

SEC filings (opens in a new tab)

In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Fennec Pharmaceuticals Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of FENC: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Q2 2022	Change
Holders	28	28	0
Shares	11.4M	11.3M	−156.6K (−1.4%)
Value	$64.1M	$63.2M	−$877.4K (−1.4%)

New holders (1)

Institutions that held Fennec Pharmaceuticals Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to FENC in Q2 2022
Institution	Shares	Value	% of portfolio
Simplex Trading, LLC	2,177	$12.0K	0.00%

Sold out (1)

Institutions that held Fennec Pharmaceuticals Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of FENC in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Fortitude Advisory Group L.L.C.	1,500	$8.00K